查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083414

糖尿病護理設備市場：2026-2032年全球市場預測（按設備類型、技術、給藥方法、胰島素類型、分銷管道和最終用戶分類）

Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，糖尿病護理設備市場將成長至 777.2 億美元，複合年成長率為 13.42%。

主要市場統計數據
基準年 2025 321.8億美元
預計年份：2026年 363.4億美元
預測年份 2032 777.2億美元
複合年成長率 (%) 13.42%

糖尿病護理設備正從一次性監測工具轉向聯網的、數據驅動的系統，以支援在包括家庭、診所、藥房和醫院在內的所有環境中進行持續的糖尿病管理。這一類別包括血糖值監測系統、持續血糖監測儀、胰島素筆、胰島素幫浦、智慧筆蓋、採血針、輸液器和整合數位平台。

全球糖尿病負擔是推動需求成長的主要因素。根據國際糖尿病聯盟 (IDF) 估計，2021 年全球有 5.37 億成年人患有糖尿病，預計到 2045 年將達到 7.83 億。這種持續的臨床需求正在加速推廣持續血糖監測、自動胰島素輸注和可互通的糖尿病技術，旨在改善血糖控制、降低低血糖風險並支持以價值為導向的醫療保健。

糖尿病醫療設備引進方面的變革性變化

糖尿病照護設備的格局正在重塑，治療模式正從被動治療轉向主動、個人化的疾病管理。持續血糖監測的應用範圍已從第1型糖尿病擴展到包括接受胰島素治療的第二型糖尿病患者、妊娠期糖尿病患者、出院後居家追蹤模式患者的風險管理。保險覆蓋範圍的擴大、藥房的普及以及人性化的感測器設計正在降低患者的使用門檻。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過將血糖值、胰島素、飲食、活動水平和睡眠等高頻數據轉化為及時的訊息，從而提升糖尿病護理設備的臨床價值。在自動胰島素輸注系統中，演算法會根據感測器檢測到的血糖值趨勢調整基礎胰島素和校正劑量，在臨床指導下合理使用，有助於提高血糖在目標範圍內的時間。

關於糖尿病照護設備的關鍵區域見解

由於中國和印度糖尿病患者數量龐大、醫療成本不斷上漲、藥房覆蓋範圍擴大以及連網血糖監測的日益普及，亞太地區已成為糖尿病護理設備的重要市場。在日本、韓國和澳大利亞，由於完善的保險報銷體系、醫療專業人員對基於感測器的護理技術的理解以及支持遠端監測的數位醫療基礎設施，先進糖尿病技術的應用正在加速推進。

全球衛生經濟學領域的關鍵小組見解

由於都市區醫療保健投資、藥屋主導的藥品獲取管道拓展、私人保險的普及以及糖尿病自我管理意識的提高，東協市場正在擴張，儘管各成員國的報銷機制仍存在差異。在高糖尿病盛行率、政府主導的數位轉型以及公共和私營醫療保健系統日益普及互聯醫療模式的推動下，海灣合作理事會（GCC）國家正將糖尿病相關技術作為更廣泛的非傳染性疾病策略的優先事項。

主要國家關鍵醫療設備市場的發展趨勢

美國在糖尿病護理設備創新、全面的醫療保險覆蓋以及持續血糖監測和自動胰島素輸注的應用方面處於世界領先地位。根據美國疾病管制與預防中心（CDC）統計，美國有3,840萬名糖尿病患者。在加拿大，由於各省醫療保險覆蓋範圍不同以及專科醫生主導的糖尿病項目，這些技術的普及率正在穩步提高。同時，墨西哥和巴西對價格合理的血糖監測和胰島素輸註解決方案的需求日益成長，這些產品在藥局的供應也不斷擴大。

為醫療設備業領導者提供的實用建議

行業領導企業應優先考慮基於循證醫學的產品差異化，尤其是在準確性、易用性、佩戴時間、互通性以及可衡量的結果方面，例如提高血糖達標時間、減少低血糖發作次數和降低急診治療的使用率。針對第 1 型糖尿病、需要胰島素治療的第 2 型糖尿病、妊娠相關應用、兒童和老年人群建立臨床證據，有助於提高保險公司的接受度和臨床醫生的信心。

調查方法

本次高階主管評估基於檢驗的公共衛生指標、監管趨勢、臨床應用模式、報銷趨勢以及影響糖尿病護理設備的技術趨勢。評估的資訊來源通常包括國際糖尿病負擔數據、國家衛生機構和監管機構的指導意見、同行評審的臨床證據、臨床實踐指南以及官方產品核可。

結論

糖尿病護理設備領域正朝著更協作、智慧化和以結果為導向的方向發展。持續血糖監測、智慧胰島素輸注、數位指導和人工智慧分析正在重新定義患者和臨床醫生如何制定日常血糖管理決策。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 糖尿病照護設備市場：依設備類型分類

  • 人工胰臟系統
    • 全閉合迴路
    • 混合封閉式
  • 血糖監測設備
    • 持續血糖監測
    • 瞬時血糖監測
    • 自測血糖
  • 注射輔助器具
    • 點滴器
    • 筆針
    • 針頭
  • 胰島素筆
    • 預填充一次性筆
    • 可重複使用的筆
    • 智慧筆
  • 胰島素幫浦
    • 貼片幫浦
    • 管式幫浦
  • 胰島素注射器

第8章 糖尿病護理設備市場：依技術分類

  • 持續血糖監測
    • 即時連續血糖監測
    • 回顧性連續血糖監測
  • 瞬時血糖監測
  • 自測血糖
    • 血糖值儀
    • 《採血針》
    • 測試條

第9章 糖尿病護理設備市場：依給藥方式分類

  • 持續管理
  • 間歇性給藥

第10章 糖尿病照護設備市場：依胰島素類型分類

  • 中間作用類型
  • 長效型
    • 德特米爾
    • 格拉金
  • 快速起效
    • Aspart
    • Glulisine
    • Lispro
  • 短效
  • 超長效

第11章 糖尿病護理設備市場：依通路分類

  • 線上管道
  • 離線
    • 零售藥房
    • 醫院藥房

第12章 糖尿病護理設備市場：依最終用戶分類

  • 診斷中心
  • 居家照護
  • 醫院和診所
    • 糖尿病診所
    • 一般診所

第13章 糖尿病照護設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 糖尿病照護設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 糖尿病照護設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Acon Laboratories Inc.
  • ARKray Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton Dickinson and Company BD
  • Bionime Corporation
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Menarini Diagnostics
  • MicroTech Medical Inc.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Sanofi
  • Senseonics Holdings Inc.
  • Sinocare
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Trividia Health
  • Valeritas Holdings Inc.
  • Ypsomed Holding AG
Product Code: MRR-43539E5D2EA5

The Diabetes Care Devices Market is projected to grow by USD 77.72 billion at a CAGR of 13.42% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 32.18 billion
Estimated Year [2026] USD 36.34 billion
Forecast Year [2032] USD 77.72 billion
CAGR (%) 13.42%

Diabetes care devices are moving from episodic monitoring tools to connected, data-enabled systems that support continuous diabetes management across home, clinic, pharmacy, and hospital settings. The category includes blood glucose monitoring systems, continuous glucose monitors, insulin pens, insulin pumps, smart pen caps, lancets, infusion sets, and integrated digital platforms.

Demand is supported by the global diabetes burden. The International Diabetes Federation estimates that 537 million adults were living with diabetes in 2021 and projects 783 million by 2045. This sustained clinical need is accelerating adoption of continuous glucose monitoring, automated insulin delivery, and interoperable diabetes technology designed to improve glycemic control, reduce hypoglycemia risk, and support value-based care.

Transformative Shifts in Diabetes Device Adoption

The diabetes care devices landscape is being reshaped by the shift from reactive treatment to proactive, personalized disease management. Continuous glucose monitoring is expanding beyond type 1 diabetes into insulin-treated type 2 diabetes, gestational diabetes risk management, and hospital-to-home follow-up models. Reimbursement expansion, pharmacy distribution, and consumer-friendly sensor design are reducing access barriers.

Interoperability is another structural shift. Regulatory pathways such as the U.S. FDA's integrated continuous glucose monitoring designation and alternate controller enabled infusion pump framework have encouraged device ecosystems that combine sensors, pumps, algorithms, and mobile applications. Manufacturers are competing on accuracy, wear duration, ease of insertion, data security, cloud connectivity, and integration with electronic health records.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasing the clinical value of diabetes care devices by turning high-frequency glucose, insulin, meal, activity, and sleep data into timely insights. In automated insulin delivery, algorithms help adjust basal insulin and correction dosing based on sensor glucose trends, supporting improved time in range when used appropriately under clinical guidance.

AI-enabled analytics also support remote patient monitoring, population risk stratification, personalized coaching, and early detection of adherence gaps. The cumulative impact is a move toward predictive diabetes management; however, industry leaders must validate algorithms across diverse populations, address bias, maintain cybersecurity, and comply with evolving medical device software requirements.

Key Regional Insights for Diabetes Care Devices

Asia-Pacific is a major diabetes care devices region due to large diabetes populations in China and India, rising healthcare expenditure, expanding pharmacy access, and broader availability of connected glucose monitoring. Japan, South Korea, and Australia show strong uptake of advanced diabetes technology due to established reimbursement pathways, clinician familiarity with sensor-based care, and digital health infrastructure supporting remote monitoring.

North America remains a leading innovation and commercialization hub, supported by FDA-cleared continuous glucose monitoring and automated insulin delivery systems, strong payer coverage for insulin users, high smartphone penetration, and broad adoption of digital health workflows. Europe benefits from national health systems, CE-marked technologies, structured diabetes programs, and growing emphasis on real-world evidence under stricter device regulation. Latin America shows rising demand for affordable glucose meters, strips, insulin delivery supplies, and selective CGM access, with Brazil and Mexico anchoring regional adoption. The Middle East is advancing diabetes prevention, screening, and connected care initiatives, particularly across high-income Gulf health systems. Africa continues to face affordability, distribution, and specialist access constraints, making essential blood glucose monitoring, test strips, and reliable insulin delivery supplies central to diabetes care priorities.

Key Group Insights Across Global Health Economies

ASEAN markets are expanding through urban healthcare investment, pharmacy-led access, private insurance uptake, and rising awareness of diabetes self-management, although reimbursement remains uneven across member states. The GCC is prioritizing diabetes technology as part of broader noncommunicable disease strategies, supported by high diabetes prevalence, government-backed digital transformation, and increasing deployment of connected care models in public and private healthcare systems.

The European Union benefits from regulatory harmonization under the Medical Device Regulation, cross-border clinical evidence expectations, and established public reimbursement mechanisms, while manufacturers face stronger requirements for clinical evaluation, post-market surveillance, and data protection. BRICS countries represent significant patient-access opportunities because of large diabetes populations, led by China, India, and Brazil, with procurement, affordability, and local manufacturing policies influencing adoption. G7 markets are central to premium device adoption, reimbursement evidence generation, and clinical guideline integration. NATO countries overlap heavily with advanced reimbursement systems and regulated medtech supply chains, increasing the importance of cybersecurity, continuity of supply, and data governance for connected diabetes care devices.

Key Country Insights for Priority Device Markets

The United States leads in diabetes care device innovation, reimbursement depth, and use of continuous glucose monitoring and automated insulin delivery, with the CDC reporting 38.4 million Americans with diabetes. Canada shows steady uptake supported by provincial coverage variability and specialist-driven diabetes programs, while Mexico and Brazil present expanding demand for affordable glucose monitoring, insulin delivery solutions, and broader pharmacy availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing sensor-based diabetes management through public health systems, clinical guidelines, and structured chronic disease programs, although reimbursement rules and eligibility criteria differ by country. Russia remains a complex market due to procurement dynamics, regulatory considerations, and supply continuity. In Asia-Pacific, China and India offer scale supported by large diabetes populations and expanding domestic healthcare capacity, Japan prioritizes quality, accuracy, and reimbursement-supported innovation, Australia has strong diabetes technology access programs, and South Korea combines advanced digital health capability with rising adoption of connected glucose monitoring and insulin delivery devices.

Actionable Recommendations for Device Leaders

Industry leaders should prioritize evidence-backed product differentiation, especially accuracy, usability, wear time, interoperability, and measurable outcomes such as improved time in range, fewer hypoglycemic events, and lower acute-care utilization. Building clinical evidence across type 1 diabetes, insulin-treated type 2 diabetes, pregnancy-related use cases, pediatrics, and older adults can strengthen payer acceptance and clinician confidence.

Companies should also localize affordability strategies through tiered portfolios, pharmacy distribution, subscription models, patient support services, and partnerships with telehealth providers. Cybersecurity, data privacy, regulatory readiness, human factors engineering, and responsible AI governance must be embedded early in product development to protect patient trust and reduce commercialization risk.

Research Methodology

This executive assessment is structured around verified public health indicators, regulatory developments, clinical adoption patterns, reimbursement dynamics, and technology trends affecting diabetes care devices. Sources typically evaluated include international diabetes burden data, national health agencies, regulator guidance, peer-reviewed clinical evidence, clinical practice recommendations, and public product clearances.

The methodology emphasizes triangulation across demand drivers, device utilization trends, regional access conditions, and health system priorities. Market interpretation focuses on practical decision-making for manufacturers, distributors, providers, payers, and investors while avoiding unsupported claims and separating established trends from emerging opportunities.

Conclusion

The diabetes care devices landscape is entering a more connected, intelligent, and outcomes-oriented phase. Continuous glucose monitoring, smart insulin delivery, digital coaching, and AI-enabled analytics are redefining how patients and clinicians manage daily glycemic decisions.

Long-term progress will depend on clinical validation, affordability, regulatory compliance, equitable access, cybersecurity, and seamless integration into care pathways. Organizations that combine device reliability with actionable data, strong reimbursement evidence, and patient-centered design will be best positioned to lead the next generation of diabetes management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Diabetes Care Devices Market, by Device Type

  • 7.1. Artificial Pancreas Systems
    • 7.1.1. Full Closed Loop
    • 7.1.2. Hybrid Closed Loop
  • 7.2. Glucose Monitoring Devices
    • 7.2.1. Continuous Glucose Monitoring
    • 7.2.2. Flash Glucose Monitoring
    • 7.2.3. Self Monitoring Blood Glucose
  • 7.3. Injection Aids
    • 7.3.1. Infusion Sets
    • 7.3.2. Pen Needles
    • 7.3.3. Syringe Needles
  • 7.4. Insulin Pens
    • 7.4.1. Prefilled Disposable Pens
    • 7.4.2. Reusable Pens
    • 7.4.3. Smart Pens
  • 7.5. Insulin Pumps
    • 7.5.1. Patch Pumps
    • 7.5.2. Tubed Pumps
  • 7.6. Insulin Syringes

8. Diabetes Care Devices Market, by Technology

  • 8.1. Continuous Glucose Monitoring
    • 8.1.1. Real Time Continuous Glucose Monitoring
    • 8.1.2. Retrospective Continuous Glucose Monitoring
  • 8.2. Flash Glucose Monitoring
  • 8.3. Self Monitoring Blood Glucose
    • 8.3.1. Glucose Meters
    • 8.3.2. Lancets
    • 8.3.3. Test Strips

9. Diabetes Care Devices Market, by Delivery Mode

  • 9.1. Continuous Delivery
  • 9.2. Intermittent Delivery

10. Diabetes Care Devices Market, by Insulin Type

  • 10.1. Intermediate Acting
  • 10.2. Long Acting
    • 10.2.1. Detemir
    • 10.2.2. Glargine
  • 10.3. Rapid Acting
    • 10.3.1. Aspart
    • 10.3.2. Glulisine
    • 10.3.3. Lispro
  • 10.4. Short Acting
  • 10.5. Ultra Long Acting

11. Diabetes Care Devices Market, by Distribution Channel

  • 11.1. Online Channels
  • 11.2. Offline
    • 11.2.1. Retail Pharmacies
    • 11.2.2. Hospital Pharmacies

12. Diabetes Care Devices Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Home Care
  • 12.3. Hospitals And Clinics
    • 12.3.1. Diabetes Clinics
    • 12.3.2. General Clinics

13. Diabetes Care Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Diabetes Care Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Diabetes Care Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Acon Laboratories Inc.
  • 17.3. ARKray Inc.
  • 17.4. Ascensia Diabetes Care Holdings AG
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton Dickinson and Company BD
  • 17.7. Bionime Corporation
  • 17.8. Dexcom Inc.
  • 17.9. Eli Lilly and Company
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. Insulet Corporation
  • 17.12. LifeScan Inc.
  • 17.13. Medtronic plc
  • 17.14. Menarini Diagnostics
  • 17.15. MicroTech Medical Inc.
  • 17.16. Nipro Corporation
  • 17.17. Novo Nordisk A/S
  • 17.18. Sanofi
  • 17.19. Senseonics Holdings Inc.
  • 17.20. Sinocare
  • 17.21. Tandem Diabetes Care Inc.
  • 17.22. Terumo Corporation
  • 17.23. Trividia Health
  • 17.24. Valeritas Holdings Inc.
  • 17.25. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIABETES CARE DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INJECTION AIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INJECTION AIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INJECTION AIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INFUSION SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INFUSION SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INFUSION SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PEN NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PEN NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INSULIN PENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INSULIN PENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INSULIN PENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REUSABLE PENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REUSABLE PENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REUSABLE PENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SMART PENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SMART PENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SMART PENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PATCH PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PATCH PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PATCH PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TUBED PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TUBED PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TUBED PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INSULIN SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INSULIN SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INSULIN SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GLUCOSE METERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLUCOSE METERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LANCETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL LONG ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LONG ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LONG ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DETEMIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DETEMIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DETEMIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GLARGINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GLARGINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GLARGINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RAPID ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RAPID ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RAPID ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ASPART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ASPART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ASPART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GLULISINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GLULISINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GLULISINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL LISPRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL LISPRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL LISPRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SHORT ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SHORT ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SHORT ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DIABETES CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIABETES CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DIABETES CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GENERAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GENERAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL GENERAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. GCC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. GCC DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 285. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. GCC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 289. GCC DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 290. GCC DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 291. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. GCC DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 293. GCC DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 294. GCC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. GCC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. GCC DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 334. G7 DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. G7 DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. G7 DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 337. G7 DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 338. G7 DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
  • TABLE 339. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
  • TABLE 340. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 341. G7 DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 342. G7 DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 343. G7 DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
  • TABLE 344. G7 DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 345. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. G7 DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
  • TABLE 347. G7 DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 348. G7 DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 349. G7 DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 350. G7 DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. G7 DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 352. NATO DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. NATO DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. NATO DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 355. NATO DIABETES CARE DEVICES MARKET SIZE, BY GLU